WO2005088388A1 - Variable focus lens - Google Patents

Variable focus lens Download PDF

Info

Publication number
WO2005088388A1
WO2005088388A1 PCT/IB2005/050699 IB2005050699W WO2005088388A1 WO 2005088388 A1 WO2005088388 A1 WO 2005088388A1 IB 2005050699 W IB2005050699 W IB 2005050699W WO 2005088388 A1 WO2005088388 A1 WO 2005088388A1
Authority
WO
WIPO (PCT)
Prior art keywords
variable focus
focus lens
lens according
wall
lens
Prior art date
Application number
PCT/IB2005/050699
Other languages
French (fr)
Inventor
Stein Kuiper
Bernardus H. W. Hendriks
Original Assignee
Koninklijke Philips Electronics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0404996A external-priority patent/GB0404996D0/en
Application filed by Koninklijke Philips Electronics N.V. filed Critical Koninklijke Philips Electronics N.V.
Priority to US10/598,258 priority Critical patent/US7311398B2/en
Priority to EP05708847A priority patent/EP1728117A1/en
Priority to JP2007501415A priority patent/JP2007526517A/en
Publication of WO2005088388A1 publication Critical patent/WO2005088388A1/en

Links

Classifications

    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B26/00Optical devices or arrangements for the control of light using movable or deformable optical elements
    • G02B26/004Optical devices or arrangements for the control of light using movable or deformable optical elements based on a displacement or a deformation of a fluid
    • G02B26/005Optical devices or arrangements for the control of light using movable or deformable optical elements based on a displacement or a deformation of a fluid based on electrowetting
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B3/00Simple or compound lenses
    • G02B3/12Fluid-filled or evacuated lenses
    • G02B3/14Fluid-filled or evacuated lenses of variable focal length
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04Contact lenses for the eyes
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/08Auxiliary lenses; Arrangements for varying focal length
    • G02C7/081Ophthalmic lenses with variable focal length
    • G02C7/085Fluid-filled lenses, e.g. electro-wetting lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1624Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
    • A61F2/1627Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing index of refraction, e.g. by external means or by tilting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1624Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
    • A61F2/1635Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing shape

Definitions

  • the present invention relates to the field of variable focus lenses.
  • the present invention has particular, but not exclusive, application to intraocular or implanted eye lenses, and to contact lenses for placement on an exterior surface of an eye.
  • Many people suffer from myopia. Often, as people get older they start suffering from hyperopia as well.
  • a common solution for this problem is to wear varifocus spectacles in which the focal length of a lens changes from top to bottom.
  • many people do not like wearing such spectacles, preferring instead to have separate pairs.
  • Varifocal spectacles are positioned in a region outside of a human eye. It is also possible to correct eyesight defects by using intraocular techniques.
  • the paper entitled 'On the possibility of intraocular adaptive optics' by Gleb Vdovin et al. in Optics Express (No.7 2003) describes the possibility to replace malfunctioning human eye lenses by adaptive eye lenses. In particular, the use of liquid crystal based lenses is proposed, since such lenses may consume very little power.
  • actuation may be achieved by the use of inductive or capacitive power coupling.
  • a problem exists with the use of a liquid crystal based eye lens in that in order to have sufficiently low switching time the liquid crystal layer must be thinner than about 50 microns. This has the unfortunate drawback in that the optical power range of such a lens is constricted to about 3 dioptres.
  • liquid crystal lenses may give rise to astigmatism effects when light rays enter the lens obliquely.
  • any corrective varifocus eye lens has material requirements in that any materials used should be biocompatible and not toxic. In the case of a liquid crystal lens this significantly limits the choice of materials available.
  • variable focus lens which is biocompatible and has a focal power which can be varied in a relatively efficient manner.
  • a variable focus lens for an eye comprising a transparent rear wall, a transparent front wall, a cavity formed between the transparent front wall and the transparent rear wall, first and second immiscible fluids of differing refractive index contained within said cavity, and electrodes to which a voltage is able to be applied to change the curvature of a fluid meniscus between the two fluids, wherein at least the rear wall of the lens includes a biocompatible material, which material provides for biocompatibility of the lens with the eye.
  • variable focus lens By changing the curvature of the fluid meniscus and by an appropriate selection of the refractive index of the first and the second fluids, light passing through the variable focus lens, via the front wall and the rear wall, can be variably focused over a relatively large range of focal powers.
  • Operation of the lens is based upon an electrowetting principle in which the application of the voltage provides electrowetting forces which cause the meniscus to adopt a certain curvature. Variation of the voltage causes a variation of this curvature and, consequently, a variation in the focal power of the lens in a relatively efficient and simple manner.
  • At least one of the front wall and rear wall have a curved surface.
  • a curvature of the curved surface, of at least one of the front wall and the rear wall, can be selected to provide a lens with a fixed focal power which complements the focal power provided by the curvature of the fluid meniscus.
  • the front wall and the rear wall are convex.
  • the front wall includes a biocompatible material, which material provides for biocompatibility of the lens with the eye, and the lens is adapted for implantation in a human eye.
  • the variable focus lens can be implanted in a human eye in order to replace a defective human eye lens.
  • the front wall is convex and the rear wall is concave.
  • the lens is in the form of a contact lens for placement on an exterior surface of a human eye.
  • the contact lens can be placed on an exterior surface of a human eye.
  • a defective eyesight of the human can be improved in a relatively simple manner without the need for a surgical procedure.
  • the implanted lens or the contact lens in accordance with embodiments of the present invention allows a human's defective eyesight to be improved such that the human can clearly view different objects requiring a different level of focal power.
  • at least one of the first fluid and the second fluid includes a biocompatible material, which material provides for biocompatibility of the lens with the eye.
  • the biocompatible material of any of the rear wall, the front wall, the first fluid and the second fluid is non-toxic to, and compatible with, biological tissues of the eye.
  • any complications for example an irritation, caused by the front and/or the rear wall of the lens being in contact with tissues of the eye, are relatively minimal.
  • the biocompatibility of the fluids minimises any risk of such complications occurring if the leaking fluids make contact with the eye tissues. Should any molecules of the first and/or second fluid diffuse through the front or rear wall, any such complications are similarly minimised by the biocompatibility of the fluids.
  • the fluid mensicus has a contact angle with one of the front and rear walls, the contact angle determining the curvature of the fluid meniscus, and wherein at least a first of the electrodes is positioned in the lens to enable variation of the contact angle between the fluid meniscus and the wall through controlled application of the voltage, thereby altering the curvature of the fluid meniscus.
  • the first electrode is placed on the front wall.
  • the first and second fluids are of substantially identical specific gravity. With the first and second fluids being of substantially identical specific gravity, the lens does not need to have a certain orientation in order to function correctly.
  • the curvature of the fluid meniscus is varied by applying the voltage to the electrodes via one of: capacitive coupling, inductive coupling, or optical coupling.
  • the human can actuate and control the focus of the lens implanted in, or placed on, their eye by varying the voltage applied to the fluid meniscus.
  • the powering of the lens to control the focus can be performed remotely to the eye such that the human does not need to make contact with the lens of the invention itself.
  • FIGS. 1 to 3 show schematically a variable focus lens having different fluid meniscus curvatures in accordance with an embodiment of the present invention.
  • Figure 4 shows schematically a variable focus lens in accordance with a different embodiment of the present invention.
  • Figures 1 to 3 show a variable focus lens 2 in accordance with an embodiment of the present invention.
  • Figures 1 , 2 and 3 show, respectively, a fluid meniscus 4 of the lens 2 having a convex, planar and concave curvature, respectively.
  • the variable focus lens 2 is in the form of a contact lens 2 for placement on an exterior surface of a human eye (not indicated).
  • the lens 2 comprises a transparent front wall 6 and a transparent rear wall 8.
  • the front wall 6 and the rear wall 8 are formed of a biocompatible material, for example polymethylmethacrylate (PMMA), a hydrogel polymer, hydroxyethylmethacrylate (HEMA), silicone rubber, a cyclic olefin copolymer (COC), or glass, which provides for biocompatibility of the lens 2 with the eye.
  • PMMA polymethylmethacrylate
  • HEMA hydroxyethylmethacrylate
  • COC cyclic olefin copolymer
  • the front wall 6 has a convex curvature such that the front wall 6 has a convex curved surface 10.
  • the rear wall 8 has a concave curvature such that the rear wall 8 has a concave curved surface 12.
  • the convex and the concave curvature of the front wall 6 and the rear wall 8, respectively, are rotationally symmetric about an optical axis OA of the lens 2.
  • a thickness of the cavity between the front wall 6 and the rear wall 8 in a direction parallel the optical axis OA is greater than approximately 50mm.
  • the front wall and the rear walls 6, 8 each form a lens having a fixed focal power which is determined by the curvature, the refractive index of the materials and a thickness in a direction parallel the optical axis OA of the front and rear walls 6, 8.
  • the fixed focal power is also determined by the material and refractive index of fluids in contact with the walls 6, 8. A description of these fluids follows. A periphery of the front wall 6 and a periphery of the rear wall 8 are joined at a joining region J to form a cavity 14.
  • the cavity 14 contains a first fluid 16 and a second fluid 17 which are immiscible, which each have a different refractive index and which are each formed of a material which is biocompatible with the eye.
  • the fluid meniscus 4 lies between the first fluid 16 and the second fluid 17 so as to separate the two fluids 16, 17.
  • the first fluid 16 is a non- electrically conductive oil, for example silicone oil, which is disposed in the cavity 14 between the second fluid 17 and the front wall 6, and the second fluid 17 is an electrolyte, for example a mixture of salt and water having a low concentration, which is disposed in the cavity 14 between the first fluid 16 and the rear wall 8.
  • the low concentration corresponds to that of a physiological (human body based) salt solution of approximately 0.9% NaCI in water.
  • the second fluid 17 may alternatively be glycerol or diethylene glycol.
  • the first fluid is electrically conductive but is less electrically conductive than the second fluid 17.
  • the first and second fluid 16, 17 each have a substantially identical specific gravity.
  • first and the second fluid 16, 17 each have a desired optical dispersion (indicated by a material's Abbe number), so that the contact lens 2 can improve a positive and/or a negative chromatic aberration of a defective eyesight.
  • a first electrode 18 is annular and is placed on the front wall 6 so as to extend around a periphery of an inner surface 19 of the front wall 6. In further embodiments of the present invention, the first electrode 18 is alternatively positioned in or in proximity to the front wall 6.
  • the inner surface 19 is coated with a layer 20 of material, for example TeflonTMAF 1600 produced by DuPontTM, which is electrically insulating and hydrophobic.
  • a second electrode 21 is placed on an inner surface 22 of the rear wall 8 and lies in direct contact with the second fluid 17.
  • the first and the second electrodes 18, 21 are both formed of a transparent and electrically conducting material such as indium tin oxide (ITO), and are electrically connected to a voltage source system 24.
  • ITO indium tin oxide
  • the fluid meniscus 4 has a contact angle ⁇ with the front wall 6 which determines the curvature of the fluid meniscus 4.
  • the voltage source system 24 applies a voltage to the first and the second electrode 18, 21 which determines a size of the contact angle b, and consequently the curvature of the meniscus 4.
  • the first electrode 18 and the second electrode 21 are positioned in the lens 2 to enable variation of the size of the contact angle b through a controlled application of the voltage in order to alter the curvature of the fluid meniscus 4. In this way a focal power of the lens 2, acting upon a beam of light passing through the lens 2, can be varied.
  • the fluid meniscus 4 is shown in Figure 1 having a convex curvature when viewed from the front wall 6.
  • An appropriate voltage applied to the first and second electrodes 18, 21 determines the size of the contact angle b such that the curvature is convex.
  • Figure 2 shows the fluid meniscus 4 having a planar curvature.
  • FIG. 1 shows the contact angle ⁇ is greater than that shown in Figure 1, such that the meniscus curvature is planar.
  • Figure 3 shows the fluid meniscus 4 having a concave curvature when viewed from the front wall 6.
  • An appropriate different voltage is applied to the first and the second electrode 18, 21 such that the contact angle ⁇ is greater than that shown in Figures 1 and 2 such that the meniscus curvature is concave.
  • the meniscus 4 has a same sign of curvature as that of the cornea of the eye receiving the contact lens 2.
  • an optically active area of the lens 2 should be of the order of the diameter of the pupil of the human eye which is approximately 8mm or less. It is envisaged that, with the thickness of the cavity 14 being greater than approximately
  • the focal power of the lens 2 can be varied between a range of positive focal powers of approximately 0 to 50 dioptres in a time of approximately 50ms by varying the contact angle b between a maximum and a minimum size.
  • the focal power of the lens 2 can alternatively be varied between a range of negative and positive focal powers of approximately -25 to +25 dioptres in a time of approximately
  • the focal power of the lens 2 can be varied between approximately 0 to 50 dioptres, or approximately
  • a patient who wears a contact lens 2 in accordance with this embodiment can actuate and control the variable focus of the lens 2 using the voltage source system 24 in a wireless manner. Variation of the curvature of the meniscus 4 by the applied voltage occurs in a capacitive manner such that a relatively low applied voltage is required.
  • the voltage source system 24 uses a capacitive coupling technique to remotely control the variable focus of the lens 2.
  • the lens 2 includes a coil of a transparent and electrically conductive material, for example indium tin oxide (ITO), which is mounted on either of the walls 6, 8 of the lens 2, or on a circumference of the lens 2.
  • ITO indium tin oxide
  • the patient can use a control unit (not indicated) to wirelessly supply power and control the variable focus of the lens 2 by an inductive coupling technique.
  • the voltage source system 24 includes a photocell (not indicated) and the patient can use a control unit (not indicated) to wirelessly supply power and control the variable focus of the lens 2 by optical coupling, using for example infrared electromagnetic radiation.
  • triggering the change in focal power of the lens 2 by the patient is accomplished relatively simply by the provision of a control unit comprising a power unit and a button on, for example, an "empty" spectacle frame.
  • the patient controls the variation of focal power of the lens 2 using a pattern of blinks.
  • an inclusion of distance measuring apparatus enables an automatic focusing system to be provided to the patient. Further details of a voltage source system utilising capacitive, inductive and optical coupling techniques are included herein by way of the following reference: 'On the possibility of intraocular adaptive optics' by Gleb Vdovin et al. in Optics Express (No.7 2003).
  • the lens 2 is particularly useful to users with both short and long distance eyesight correction requirements.
  • Changing the focal length of the lens 2 could, for example, be used to change between a focal length suitable for distance vision and a focal length suitable for reading vision.
  • the choice of materials for the front and rear walls 6, 8 can be chosen to achieve a hard type of contact lens (plastic housing) or a soft lens arrangement of contact lens.
  • the curvature of the front and rear walls should be chosen so as to mimic the curvature and size of a patients eyeball.
  • FIG. 4 shows a variable focus lens 26 in accordance with a different embodiment of the present invention.
  • the variable focus lens 26 is adapted for implantation in a human eye (not indicated).
  • a periphery of the front wall 106 is joined at a joining region J to a periphery of a rear wall 28.
  • the rear wall 28 has a convex curvature such that the rear wall has a convex curved surface 30.
  • the convex curvature of the rear wall 28 is rotationally symmetric about the optical axis OA of the lens 26.
  • a thickness of the cavity 114 between the front wall 106 and the rear wall 28 in a direction parallel the optical axis OA is greater than approximately 50mm.
  • Both the front wall 106 and the rear wall 28 are formed of a transparent material which is biocompatible with the eye.
  • This biocompatible material is, for example, one of the biocompatible materials detailed for the embodiment described previously using Figures 1 to 3.
  • the size of the lens 26 corresponds approximately with that of the human eye lens itself. Hence a diameter of the lens 26 is approximately 10mm and a total thickness, in a direction parallel the optical axis OA, of the lens 26 is approximately 4mm.
  • the lens 26 of this embodiment preferably provides only a positive focal power.
  • the lens 26 is implanted in a human eye using a surgical technique where a human eye lens, which, for example has a cataract, is removed, via an incision in the eye, and replaced with the variable focus lens 26 of this embodiment.
  • a human eye lens which, for example has a cataract
  • the curvature of the meniscus 104 can be varied using the voltage source 124 to obtain convex, planar and concave meniscus curvatures when viewed from the front wall 106, in a similar manner to that described previously.
  • Figure 4 shows the fluid meniscus 4 having a convex curvature when viewed from the front wall 106.
  • fluids having certain refractive indices and optical dispersion values are detailed. It is envisaged that in further embodiments of the present invention fluids having different of such values may be used and may be fluids of a different material to those described previously. Furthermore, a thickness of the cavity, dimensions and shapes of features of the lens, curvatures of the walls and certain focal powers which can be achieved by the lens, have been detailed. It is envisaged that in further embodiments of the invention the lens may have a different thickness of the cavity, that the dimensions or shapes of features of the lens and curvatures of the walls, are different, and that different focal powers may be achieved. As described above, the fluid meniscus forms a contact angle with the front wall.
  • the meniscus may alternatively form a contact angle with the rear wall.
  • the first fluid is disposed between the rear wall and the meniscus and the second fluid is disposed between the front wall and the meniscus.
  • the arrangement of the fluids may determine whether the lens provides a positive or a negative focal power.

Abstract

A variable focus lens for an eye comprising a transparent rear wall, a transparent front wall, a cavity formed between the transparent front wall and the transparent rear wall, first and second immiscible fluids of differing refractive index contained within said cavity, and electrodes to which a voltage is able to be applied to change the curvature of a fluid meniscus between the two fluids. At least the rear wall of the lens includes a biocompatible material, which material provides for biocompatibility of the lens with the eye.

Description

DESCRIPTION
VARIABLE FOCUS LENS The present invention relates to the field of variable focus lenses. The present invention has particular, but not exclusive, application to intraocular or implanted eye lenses, and to contact lenses for placement on an exterior surface of an eye. Many people suffer from myopia. Often, as people get older they start suffering from hyperopia as well. A common solution for this problem is to wear varifocus spectacles in which the focal length of a lens changes from top to bottom. However, many people do not like wearing such spectacles, preferring instead to have separate pairs. Naturally, it is inconvenient to need to switch between different pairs of spectacles and, clearly, the currently available varifocus lenses do not meet with universal approval. They are often found to be irritating to the user, since it may be necessary to change the way that the user views an object (e.g. tilting the head) in order to view the object through an appropriate part of the varifocus lens. Varifocal spectacles are positioned in a region outside of a human eye. It is also possible to correct eyesight defects by using intraocular techniques. The paper entitled 'On the possibility of intraocular adaptive optics' by Gleb Vdovin et al. in Optics Express (No.7 2003) describes the possibility to replace malfunctioning human eye lenses by adaptive eye lenses. In particular, the use of liquid crystal based lenses is proposed, since such lenses may consume very little power. Various schemes for powering or actuating the lens are discussed, for example actuation may be achieved by the use of inductive or capacitive power coupling. However, a problem exists with the use of a liquid crystal based eye lens in that in order to have sufficiently low switching time the liquid crystal layer must be thinner than about 50 microns. This has the unfortunate drawback in that the optical power range of such a lens is constricted to about 3 dioptres. Furthermore, liquid crystal lenses may give rise to astigmatism effects when light rays enter the lens obliquely. Finally, any corrective varifocus eye lens has material requirements in that any materials used should be biocompatible and not toxic. In the case of a liquid crystal lens this significantly limits the choice of materials available. Clearly, an adaptive eye lens, which overcomes some or all of the above disadvantages, would be desirable. It is noted that International patent application WO 04/050334 discloses a method of manufacturing lens elements, such as contact lenses, using a variable fluid meniscus. The lens elements which are manufactured have a fixed focal power.
It is an object of the present invention to provide a variable focus lens which is biocompatible and has a focal power which can be varied in a relatively efficient manner. In accordance with the present invention, there is provided a variable focus lens for an eye comprising a transparent rear wall, a transparent front wall, a cavity formed between the transparent front wall and the transparent rear wall, first and second immiscible fluids of differing refractive index contained within said cavity, and electrodes to which a voltage is able to be applied to change the curvature of a fluid meniscus between the two fluids, wherein at least the rear wall of the lens includes a biocompatible material, which material provides for biocompatibility of the lens with the eye. By changing the curvature of the fluid meniscus and by an appropriate selection of the refractive index of the first and the second fluids, light passing through the variable focus lens, via the front wall and the rear wall, can be variably focused over a relatively large range of focal powers. Operation of the lens is based upon an electrowetting principle in which the application of the voltage provides electrowetting forces which cause the meniscus to adopt a certain curvature. Variation of the voltage causes a variation of this curvature and, consequently, a variation in the focal power of the lens in a relatively efficient and simple manner. As non-birefringent materials are used in a construction of the lens, light rays entering the variable focus lens of the present invention at an oblique angle are focused in a relatively accurate manner, in accordance with a current focal power of the lens. Consequently, the oblique light rays are not subjected to any astigmatic effects. In a preferred embodiment of the present invention, at least one of the front wall and rear wall have a curved surface. A curvature of the curved surface, of at least one of the front wall and the rear wall, can be selected to provide a lens with a fixed focal power which complements the focal power provided by the curvature of the fluid meniscus. In one embodiment of the present invention the front wall and the rear wall are convex. In a preferred embodiment of the present invention the front wall includes a biocompatible material, which material provides for biocompatibility of the lens with the eye, and the lens is adapted for implantation in a human eye. With the front wall and the rear wall both being convex and including the biocompatible material, the variable focus lens can be implanted in a human eye in order to replace a defective human eye lens. In one embodiment of the present invention the front wall is convex and the rear wall is concave. In a preferred embodiment of the present invention the lens is in the form of a contact lens for placement on an exterior surface of a human eye. With the front wall being convex and the rear wall being concave and at least the rear wall including a biocompatible material, the contact lens can be placed on an exterior surface of a human eye. In this way a defective eyesight of the human can be improved in a relatively simple manner without the need for a surgical procedure. The implanted lens or the contact lens in accordance with embodiments of the present invention allows a human's defective eyesight to be improved such that the human can clearly view different objects requiring a different level of focal power. In a preferred embodiment of the present invention at least one of the first fluid and the second fluid includes a biocompatible material, which material provides for biocompatibility of the lens with the eye. The biocompatible material of any of the rear wall, the front wall, the first fluid and the second fluid is non-toxic to, and compatible with, biological tissues of the eye. When the lens is implanted in, or placed on the exterior of the eye, any complications, for example an irritation, caused by the front and/or the rear wall of the lens being in contact with tissues of the eye, are relatively minimal. Furthermore, if the first fluid and/or the second fluid leak from the lens due to, for example, an accident or an improper sealing of the lens, the biocompatibility of the fluids minimises any risk of such complications occurring if the leaking fluids make contact with the eye tissues. Should any molecules of the first and/or second fluid diffuse through the front or rear wall, any such complications are similarly minimised by the biocompatibility of the fluids. In one embodiment of the present invention, the fluid mensicus has a contact angle with one of the front and rear walls, the contact angle determining the curvature of the fluid meniscus, and wherein at least a first of the electrodes is positioned in the lens to enable variation of the contact angle between the fluid meniscus and the wall through controlled application of the voltage, thereby altering the curvature of the fluid meniscus. In a preferred embodiment of the present invention, the first electrode is placed on the front wall. By placing the first electrode on the front wall of the lens, the construction of the variable focus lens is relatively compact. This allows the lens to meet necessary size criteria which allows the lens to be implanted in, or alternatively placed on the exterior surface of, the eye, without reducing the efficiency of the variation of the focus. In a preferred embodiment of the present invention, the first and second fluids are of substantially identical specific gravity. With the first and second fluids being of substantially identical specific gravity, the lens does not need to have a certain orientation in order to function correctly. In a preferred embodiment of the present invention, the curvature of the fluid meniscus is varied by applying the voltage to the electrodes via one of: capacitive coupling, inductive coupling, or optical coupling. The human can actuate and control the focus of the lens implanted in, or placed on, their eye by varying the voltage applied to the fluid meniscus. By varying the voltage using capacitive, inductive or optical coupling methods, the powering of the lens to control the focus can be performed remotely to the eye such that the human does not need to make contact with the lens of the invention itself. Additionally, the coupling methods allow control of the focus to be controlled automatically or on demand by the human, such that operation of the lens is relatively simple and efficient. Further features and advantages of the invention will become apparent from the following description of preferred embodiments of the invention, given by way of example only, which is made with reference to the accompanying drawings. Figures 1 to 3 show schematically a variable focus lens having different fluid meniscus curvatures in accordance with an embodiment of the present invention. Figure 4 shows schematically a variable focus lens in accordance with a different embodiment of the present invention.
Figures 1 to 3 show a variable focus lens 2 in accordance with an embodiment of the present invention. Figures 1 , 2 and 3 show, respectively, a fluid meniscus 4 of the lens 2 having a convex, planar and concave curvature, respectively. In this embodiment the variable focus lens 2 is in the form of a contact lens 2 for placement on an exterior surface of a human eye (not indicated). Referring to Figure 1 , the lens 2 comprises a transparent front wall 6 and a transparent rear wall 8. The front wall 6 and the rear wall 8 are formed of a biocompatible material, for example polymethylmethacrylate (PMMA), a hydrogel polymer, hydroxyethylmethacrylate (HEMA), silicone rubber, a cyclic olefin copolymer (COC), or glass, which provides for biocompatibility of the lens 2 with the eye. The front wall 6 has a convex curvature such that the front wall 6 has a convex curved surface 10. The rear wall 8 has a concave curvature such that the rear wall 8 has a concave curved surface 12. The convex and the concave curvature of the front wall 6 and the rear wall 8, respectively, are rotationally symmetric about an optical axis OA of the lens 2. A thickness of the cavity between the front wall 6 and the rear wall 8 in a direction parallel the optical axis OA is greater than approximately 50mm.The front wall and the rear walls 6, 8 each form a lens having a fixed focal power which is determined by the curvature, the refractive index of the materials and a thickness in a direction parallel the optical axis OA of the front and rear walls 6, 8. The fixed focal power is also determined by the material and refractive index of fluids in contact with the walls 6, 8. A description of these fluids follows. A periphery of the front wall 6 and a periphery of the rear wall 8 are joined at a joining region J to form a cavity 14. At the joining region J the periphery of the front wall 6 and the periphery of the rear wall 8 form an acute internal angle α. The cavity 14 contains a first fluid 16 and a second fluid 17 which are immiscible, which each have a different refractive index and which are each formed of a material which is biocompatible with the eye. The fluid meniscus 4 lies between the first fluid 16 and the second fluid 17 so as to separate the two fluids 16, 17. In this example the first fluid 16 is a non- electrically conductive oil, for example silicone oil, which is disposed in the cavity 14 between the second fluid 17 and the front wall 6, and the second fluid 17 is an electrolyte, for example a mixture of salt and water having a low concentration, which is disposed in the cavity 14 between the first fluid 16 and the rear wall 8. In this example, the low concentration corresponds to that of a physiological (human body based) salt solution of approximately 0.9% NaCI in water. In different examples the second fluid 17 may alternatively be glycerol or diethylene glycol. In a different embodiment of the present invention it is envisaged that the first fluid is electrically conductive but is less electrically conductive than the second fluid 17. The first and second fluid 16, 17 each have a substantially identical specific gravity. Additionally, the first and the second fluid 16, 17 each have a desired optical dispersion (indicated by a material's Abbe number), so that the contact lens 2 can improve a positive and/or a negative chromatic aberration of a defective eyesight. A first electrode 18 is annular and is placed on the front wall 6 so as to extend around a periphery of an inner surface 19 of the front wall 6. In further embodiments of the present invention, the first electrode 18 is alternatively positioned in or in proximity to the front wall 6. The inner surface 19 is coated with a layer 20 of material, for example Teflon™AF 1600 produced by DuPont™, which is electrically insulating and hydrophobic. A second electrode 21 is placed on an inner surface 22 of the rear wall 8 and lies in direct contact with the second fluid 17. In this example the first and the second electrodes 18, 21 are both formed of a transparent and electrically conducting material such as indium tin oxide (ITO), and are electrically connected to a voltage source system 24. The fluid meniscus 4 has a contact angle β with the front wall 6 which determines the curvature of the fluid meniscus 4. The voltage source system 24 applies a voltage to the first and the second electrode 18, 21 which determines a size of the contact angle b, and consequently the curvature of the meniscus 4. The first electrode 18 and the second electrode 21 are positioned in the lens 2 to enable variation of the size of the contact angle b through a controlled application of the voltage in order to alter the curvature of the fluid meniscus 4. In this way a focal power of the lens 2, acting upon a beam of light passing through the lens 2, can be varied. The fluid meniscus 4 is shown in Figure 1 having a convex curvature when viewed from the front wall 6. An appropriate voltage applied to the first and second electrodes 18, 21 determines the size of the contact angle b such that the curvature is convex. Figure 2 shows the fluid meniscus 4 having a planar curvature. An appropriate different voltage is applied to the first and the second electrode 18, 21 such that the contact angle β is greater than that shown in Figure 1, such that the meniscus curvature is planar. Figure 3 shows the fluid meniscus 4 having a concave curvature when viewed from the front wall 6. An appropriate different voltage is applied to the first and the second electrode 18, 21 such that the contact angle β is greater than that shown in Figures 1 and 2 such that the meniscus curvature is concave. In a preferred embodiment it is envisaged that the meniscus 4 has a same sign of curvature as that of the cornea of the eye receiving the contact lens 2. It is envisaged that with variation of the applied voltage, different sizes of the contact angle β can be achieved to obtain further different curvatures of the meniscus 4 to those shown using Figures 1 to 3. For the embodiment of the invention described using Figures 1 to 3 an optically active area of the lens 2 should be of the order of the diameter of the pupil of the human eye which is approximately 8mm or less. It is envisaged that, with the thickness of the cavity 14 being greater than approximately
50mm and the first and second fluids 16, 17 having an appropriate refractive index, the focal power of the lens 2 can be varied between a range of positive focal powers of approximately 0 to 50 dioptres in a time of approximately 50ms by varying the contact angle b between a maximum and a minimum size. In a different embodiment of the invention it is envisaged that the focal power of the lens 2 can alternatively be varied between a range of negative and positive focal powers of approximately -25 to +25 dioptres in a time of approximately
50ms. In further different embodiments where the diameter of the optically active area is approximately 3mm, it is envisaged that the focal power of the lens 2 can be varied between approximately 0 to 50 dioptres, or approximately
-25 to +25 dioptres, in a time of approximately 10ms. A patient who wears a contact lens 2 in accordance with this embodiment can actuate and control the variable focus of the lens 2 using the voltage source system 24 in a wireless manner. Variation of the curvature of the meniscus 4 by the applied voltage occurs in a capacitive manner such that a relatively low applied voltage is required. In one embodiment of the present invention, the voltage source system 24 uses a capacitive coupling technique to remotely control the variable focus of the lens 2. In an alternative embodiment of the present invention, it is envisaged that the lens 2 includes a coil of a transparent and electrically conductive material, for example indium tin oxide (ITO), which is mounted on either of the walls 6, 8 of the lens 2, or on a circumference of the lens 2. The patient can use a control unit (not indicated) to wirelessly supply power and control the variable focus of the lens 2 by an inductive coupling technique. In a yet further envisaged embodiment of the present invention, the voltage source system 24 includes a photocell (not indicated) and the patient can use a control unit (not indicated) to wirelessly supply power and control the variable focus of the lens 2 by optical coupling, using for example infrared electromagnetic radiation. In further embodiments of the invention, it is envisaged that triggering the change in focal power of the lens 2 by the patient is accomplished relatively simply by the provision of a control unit comprising a power unit and a button on, for example, an "empty" spectacle frame. Alternatively, it is envisaged that the patient controls the variation of focal power of the lens 2 using a pattern of blinks. In a further embodiment of the invention, it is envisaged that an inclusion of distance measuring apparatus enables an automatic focusing system to be provided to the patient. Further details of a voltage source system utilising capacitive, inductive and optical coupling techniques are included herein by way of the following reference: 'On the possibility of intraocular adaptive optics' by Gleb Vdovin et al. in Optics Express (No.7 2003). By controlling the focal length of the lens 2, the lens 2 is particularly useful to users with both short and long distance eyesight correction requirements. Changing the focal length of the lens 2 could, for example, be used to change between a focal length suitable for distance vision and a focal length suitable for reading vision. The choice of materials for the front and rear walls 6, 8 can be chosen to achieve a hard type of contact lens (plastic housing) or a soft lens arrangement of contact lens. The curvature of the front and rear walls should be chosen so as to mimic the curvature and size of a patients eyeball. It is envisaged that the material of the rear wall 8 may be permeable to oxygen to aid the "breathing" requirements of the eyeball, whilst in such cases interior surfaces of the cavity 14 should be coated with an impermeable coating to retain the integrity of the lens and to contain the first fluid and the second fluid 16, 17. Optionally, it may be possible to use oxygen permeable materials to form the front and rear walls 6, 8 if fluids having long-chained molecules are used for the first and the second fluid 16, 17. Hence, the construction of a variable focus, semi permeable contact lens is enabled. Figure 4 shows a variable focus lens 26 in accordance with a different embodiment of the present invention. In this embodiment the variable focus lens 26 is adapted for implantation in a human eye (not indicated). Elements and features of the lens 26 are similar to elements and features of the lens described previously using Figures 1 to 3 and are referenced using the same reference numerals, incremented by 100. Similar descriptions should be taken to apply here also. A periphery of the front wall 106 is joined at a joining region J to a periphery of a rear wall 28. The rear wall 28 has a convex curvature such that the rear wall has a convex curved surface 30. The convex curvature of the rear wall 28 is rotationally symmetric about the optical axis OA of the lens 26.
A thickness of the cavity 114 between the front wall 106 and the rear wall 28 in a direction parallel the optical axis OA is greater than approximately 50mm.
Both the front wall 106 and the rear wall 28 are formed of a transparent material which is biocompatible with the eye. This biocompatible material is, for example, one of the biocompatible materials detailed for the embodiment described previously using Figures 1 to 3. In this example, preferably the size of the lens 26 corresponds approximately with that of the human eye lens itself. Hence a diameter of the lens 26 is approximately 10mm and a total thickness, in a direction parallel the optical axis OA, of the lens 26 is approximately 4mm. Additionally, as the human eye provides a positive focus, the lens 26 of this embodiment preferably provides only a positive focal power. The lens 26 is implanted in a human eye using a surgical technique where a human eye lens, which, for example has a cataract, is removed, via an incision in the eye, and replaced with the variable focus lens 26 of this embodiment. Once the lens 26 is implanted, the curvature of the meniscus 104 can be varied using the voltage source 124 to obtain convex, planar and concave meniscus curvatures when viewed from the front wall 106, in a similar manner to that described previously. Figure 4 shows the fluid meniscus 4 having a convex curvature when viewed from the front wall 106. The above embodiments are to be understood as illustrative examples of the invention. Further embodiments of the invention are envisaged. In the described embodiments, fluids having certain refractive indices and optical dispersion values are detailed. It is envisaged that in further embodiments of the present invention fluids having different of such values may be used and may be fluids of a different material to those described previously. Furthermore, a thickness of the cavity, dimensions and shapes of features of the lens, curvatures of the walls and certain focal powers which can be achieved by the lens, have been detailed. It is envisaged that in further embodiments of the invention the lens may have a different thickness of the cavity, that the dimensions or shapes of features of the lens and curvatures of the walls, are different, and that different focal powers may be achieved. As described above, the fluid meniscus forms a contact angle with the front wall. It is envisaged that in further embodiments the meniscus may alternatively form a contact angle with the rear wall. In further alternative embodiments the first fluid is disposed between the rear wall and the meniscus and the second fluid is disposed between the front wall and the meniscus. The arrangement of the fluids may determine whether the lens provides a positive or a negative focal power. From reading the present disclosure, other modifications will be apparent to persons skilled in the art. Such modifications may involve other features which are already known in the design, manufacture and use of variable focus lenses and component parts thereof, and which may be used instead of or in addition to features already described herein.

Claims

1. A variable focus lens (2; 26) for an eye comprising a transparent rear wall (8; 28), a transparent front wall (6; 106), a cavity (14; 114) formed between the transparent front wall and the transparent rear wall, first and second immiscible fluids (16, 17) of differing refractive index contained within said cavity, and electrodes (18, 21) to which a voltage is able to be applied to change the curvature of a fluid meniscus (4; 104) between the two fluids, wherein at least the rear wall of the lens includes a biocompatible material, which material provides for biocompatibility of the lens with the eye.
2. A variable focus lens according to claim 1 , wherein at least one of the front wall and rear wall have a curved surface (10, 12; 30).
3. A variable focus lens according to claim 2, wherein the front wall and the rear wall are convex.
4. A variable focus lens according to any preceding claim, wherein the front wall includes a biocompatible material, which material provides for biocompatibility of the lens with the eye, and the lens (26) is adapted for implantation in a human eye.
5. A variable focus lens according to claim 2, wherein the front wall is convex and the rear wall is concave.
6. A variable focus lens according to claim 5, wherein the lens is in the form of a contact lens (2) for placement on an exterior surface of a human eye.
7. A variable focus lens according to any preceding claim, wherein the fluid meniscus has a contact angle (β) with one of the front and rear walls, the contact angle determining the curvature of the fluid meniscus, and wherein at least a first of the electrodes (18) is positioned in the lens to enable variation of the contact angle between the fluid meniscus and the wall through controlled application of the voltage, thereby altering the curvature of the fluid meniscus.
8. A variable focus lens according to claim 7, wherein the first electrode is positioned in or in proximity to the wall with which the fluid meniscus has a contact angle.
9. A variable focus lens according to claim 7 or 8, wherein the first electrode is annular and is placed to extend around the periphery of an inner surface of the wall with which the fluid meniscus has a contact angle.
10. A variable focus lens according to any one of claims 7 to 9, wherein the first electrode is placed on the front wall.
1 1 . A variable focus lens according to any preceding claim, wherein the distance between the front wall and rear wall is greater than 50 microns.
12. A variable focus lens according to any preceding claim, wherein the distance between the front wall and rear wall is such that an optical power of the lens can be varied between 0 and 50 dioptres by altering the curvature of the fluid meniscus.
13. A variable focus lens according to any of claims 1 to 1 1 , wherein the distance between the front wall and rear wall is such that an optical power of the lens can be varied between -25 and +25 dioptres by altering the curvature of the fluid meniscus.
14. A variable focus lens according to any preceding claim, wherein a periphery of the front wall joins a periphery of the rear wall to form an acute internal angle (α) at their joining region (J).
15. A variable focus lens according to any preceding claim, wherein the first and second fluids are of substantially identical specific gravity.
16. A variable focus lens according to any preceding claim, wherein at least one of the first fluid and the second fluid includes a biocompatible material, which material provides for biocompatibility of the lens with the eye.
17. A variable focus lens according to any preceding claim, wherein the first and second fluids are oil and an electrolyte respectively.
18. A variable focus lens according to claim 17, wherein the oil is disposed in the cavity between the electrolyte and the front transparent wall, and the electrolyte is disposed in the cavity between the oil and the rear transparent wall.
19. A variable focus lens according to claim 17, wherein the electrolyte is disposed in the cavity between the oil and the front transparent wall, and the oil is disposed in the cavity between the electrolyte and the rear transparent wall.
20. A variable focus lens according to claim 17, 18 or 19, wherein the electrolyte comprises a water/salt mixture.
21. A variable focus lens according to any preceding claim, wherein the first fluid is less conductive than the second fluid.
22. A variable focus lens according to any preceding claim, wherein the biocompatible material is polymethylmethacrylate (PMMA), a hydrogel polymer, hydroxyethylmethacrylate (HEMA), silicone rubber, a cyclic olefin copolymer (COC), or glass.
23. A variable focus lens according to any preceding claim, wherein the curvature of the fluid meniscus is varied by applying the voltage to the electrodes via one of: capacitive coupling, inductive coupling, or optical coupling.
PCT/IB2005/050699 2004-03-05 2005-02-25 Variable focus lens WO2005088388A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/598,258 US7311398B2 (en) 2004-03-05 2005-02-25 Variable focus lens
EP05708847A EP1728117A1 (en) 2004-03-05 2005-02-25 Variable focus lens
JP2007501415A JP2007526517A (en) 2004-03-05 2005-02-25 Variable focus lens

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0404996.1 2004-03-05
GB0404996A GB0404996D0 (en) 2004-03-05 2004-03-05 Adaptive eye lens
GB0423009A GB0423009D0 (en) 2004-03-05 2004-10-18 Variable focus lens
GB0423009.0 2004-10-18

Publications (1)

Publication Number Publication Date
WO2005088388A1 true WO2005088388A1 (en) 2005-09-22

Family

ID=34960617

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/050699 WO2005088388A1 (en) 2004-03-05 2005-02-25 Variable focus lens

Country Status (4)

Country Link
US (1) US7311398B2 (en)
EP (1) EP1728117A1 (en)
JP (1) JP2007526517A (en)
WO (1) WO2005088388A1 (en)

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007107589A1 (en) * 2006-03-21 2007-09-27 Varioptic Intraocular implant
WO2008062067A1 (en) * 2006-11-24 2008-05-29 Varioptic Optical lens with variable focal length
US20080306589A1 (en) * 2005-05-27 2008-12-11 Wavelight Laser Technologie Ag Intraocular Lens
US20100109175A1 (en) * 2008-10-31 2010-05-06 Pugh Randall B Processor controlled ophthalmic device
US20100110372A1 (en) * 2008-10-31 2010-05-06 Pugh Randall B Ophthalmic device with embedded microcontroller
WO2011143554A1 (en) * 2010-05-14 2011-11-17 Johnson & Johnson Vision Care, Inc. Arcuate liquid meniscus lens
WO2012015725A1 (en) * 2010-07-29 2012-02-02 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with concave torus-segment meniscus wall
WO2012015719A1 (en) * 2010-07-27 2012-02-02 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with convex torussegment meniscus wall
WO2012027156A1 (en) * 2010-08-24 2012-03-01 Johnson & Johnson Vision Care, Inc. Lens with compound linear-convex meniscus wall
WO2012027155A1 (en) * 2010-08-23 2012-03-01 Johnson & Johnson Vision Care, Inc. Negative add liquid meniscus lens
WO2012033795A1 (en) * 2010-09-08 2012-03-15 Johnson & Johnson Vision Care, Inc. Lens with multi-convex meniscus wall
WO2012044607A1 (en) * 2010-09-29 2012-04-05 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with non-spherical meniscus wall
WO2012044598A1 (en) * 2010-09-27 2012-04-05 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens including gradient thickness dielectric coating
WO2012044589A1 (en) * 2010-09-27 2012-04-05 Johnson & Johnson Vision Care, Inc. Lens with multi-segmented linear meniscus wall
CN102415935A (en) * 2011-07-22 2012-04-18 季鹏飞 Electric zoom myopia physiotherapeutic spectacles
WO2012129050A1 (en) * 2011-03-18 2012-09-27 Johnson & Johnson Vision Care, Inc. Lens with multi-concave meniscus wall
CN102768416A (en) * 2012-07-31 2012-11-07 苏州苏鼎产品设计有限公司 Layered liquid sunglasses
WO2013033349A1 (en) * 2011-08-31 2013-03-07 Johnson & Johnson Vision Care, Inc. Processor controlled intraocular lens system
CN103140779A (en) * 2010-09-29 2013-06-05 庄臣及庄臣视力保护公司 Liquid meniscus lens including variable voltage zones
EP2628044A1 (en) * 2010-10-11 2013-08-21 Adlens Beacon, Inc. Fluid filled adjustable contact lenses
US8687280B2 (en) 2010-09-29 2014-04-01 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens including meniscus wall with microchannels
US8743467B2 (en) 2010-06-29 2014-06-03 Johnson & Johnson Vision Care, Inc. Lens with conical frustum meniscus wall
CN104076526A (en) * 2013-03-15 2014-10-01 庄臣及庄臣视力保护公司 Ophthalmic lens viewing sets for three-dimensional perception of stereoscopic media
EP2778747A3 (en) * 2013-03-15 2014-11-26 Johnson & Johnson Vision Care, Inc. Ophthalmic lens viewing sets for three-dimensional perception of stereoscopic media
US9110310B2 (en) 2011-03-18 2015-08-18 Johnson & Johnson Vision Care, Inc. Multiple energization elements in stacked integrated component devices
US9158127B2 (en) 2012-03-30 2015-10-13 Johnson & Johnson Vision Care, Inc. Method and apparatus for a variable power ophthalmic lens
US9180636B2 (en) 2008-09-30 2015-11-10 Johnson & Johnson Vision Care, Inc. Variable focus ophthalmic device
AU2015224524B2 (en) * 2010-07-29 2016-10-20 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with concave torus-segment meniscus wall
US9675443B2 (en) 2009-09-10 2017-06-13 Johnson & Johnson Vision Care, Inc. Energized ophthalmic lens including stacked integrated components
US9698129B2 (en) 2011-03-18 2017-07-04 Johnson & Johnson Vision Care, Inc. Stacked integrated component devices with energization
US9703120B2 (en) 2011-02-28 2017-07-11 Johnson & Johnson Vision Care, Inc. Methods and apparatus for an ophthalmic lens with functional insert layers
US9757911B2 (en) 2013-01-09 2017-09-12 Johnson & Johson Vision Care, Inc. Method of forming a multi-piece insert device with seal for ophthalmic devices
CN107179611A (en) * 2017-07-06 2017-09-19 惠科股份有限公司 A kind of wearable device, stereoscopic picture plane play system and method
US9804418B2 (en) 2011-03-21 2017-10-31 Johnson & Johnson Vision Care, Inc. Methods and apparatus for functional insert with power layer
US9810924B2 (en) 2013-01-09 2017-11-07 Johnson & Johnson Vision Care, Inc. Multi-piece insert device with locking seal for ophthalmic devices
US9873233B2 (en) 2013-03-15 2018-01-23 Johnson & Johnson Vision Care, Inc. Ophthalmic lens viewing sets for three-dimensional perception of stereoscopic media
US9889615B2 (en) 2011-03-18 2018-02-13 Johnson & Johnson Vision Care, Inc. Stacked integrated component media insert for an ophthalmic device
WO2018190998A1 (en) * 2017-04-14 2018-10-18 Verily Life Sciences Llc Electrowetting ophthalmic optics including gas-permeable components
WO2018204027A1 (en) * 2017-05-05 2018-11-08 Verily Life Sciences Llc In situ filling and sealing of electrowetting intraocular lenses
US10251975B2 (en) 2009-02-19 2019-04-09 Neoss Limited Surface treatment process for implantable medical device
US10345620B2 (en) 2016-02-18 2019-07-09 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form biocompatible energization elements incorporating fuel cells for biomedical devices
US10361405B2 (en) 2014-08-21 2019-07-23 Johnson & Johnson Vision Care, Inc. Biomedical energization elements with polymer electrolytes
US10361404B2 (en) 2014-08-21 2019-07-23 Johnson & Johnson Vision Care, Inc. Anodes for use in biocompatible energization elements
US10367233B2 (en) 2014-08-21 2019-07-30 Johnson & Johnson Vision Care, Inc. Biomedical energization elements with polymer electrolytes and cavity structures
US10374216B2 (en) 2014-08-21 2019-08-06 Johnson & Johnson Vision Care, Inc. Pellet form cathode for use in a biocompatible battery
US10381687B2 (en) 2014-08-21 2019-08-13 Johnson & Johnson Vision Care, Inc. Methods of forming biocompatible rechargable energization elements for biomedical devices
US10386656B2 (en) 2014-08-21 2019-08-20 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form separators for biocompatible energization elements for biomedical devices
US10409089B2 (en) 2012-06-29 2019-09-10 Johnson & Johnson Vision Care, Inc. Multiple state electroactive ophthalmic device
US10451897B2 (en) 2011-03-18 2019-10-22 Johnson & Johnson Vision Care, Inc. Components with multiple energization elements for biomedical devices
US10558062B2 (en) 2014-08-21 2020-02-11 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form biocompatible energization primary elements for biomedical device
US10598958B2 (en) 2014-08-21 2020-03-24 Johnson & Johnson Vision Care, Inc. Device and methods for sealing and encapsulation for biocompatible energization elements
US10627651B2 (en) 2014-08-21 2020-04-21 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form biocompatible energization primary elements for biomedical devices with electroless sealing layers
WO2020132443A3 (en) * 2018-12-21 2020-08-13 Verily Life Sciences Llc Fluid-containing contact lens with soft posterior element
US10775644B2 (en) 2012-01-26 2020-09-15 Johnson & Johnson Vision Care, Inc. Ophthalmic lens assembly having an integrated antenna structure

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004017616D1 (en) * 2003-07-08 2008-12-18 Koninkl Philips Electronics Nv GLASS WITH VARIABLE FOCUS
US20060152672A1 (en) * 2003-07-08 2006-07-13 Koninklijke Philips Electronics N.V. Sunglasses with adaptable transmissivity
FR2887636B1 (en) * 2005-06-23 2007-08-31 Varioptic Sa VARIABLE FOCAL LENS ASSEMBLY
CN101395495B (en) * 2006-02-01 2011-12-28 瓦里奥普蒂克公司 optical electrowetting device
EP1816493A1 (en) * 2006-02-07 2007-08-08 ETH Zürich Tunable diffraction grating
US7866816B2 (en) * 2006-10-10 2011-01-11 Lane Research, Llc Variable focus spectacles
US7857850B2 (en) * 2007-02-02 2010-12-28 Adoptics Ag Interfacial refraction accommodating lens (IRAL)
US8034106B2 (en) * 2007-02-02 2011-10-11 Adoptics Ag Interfacial refraction accommodating lens (IRAL)
US20160313572A1 (en) * 2007-07-03 2016-10-27 Mitsui Chemicals, Inc. Multifocal lens with a diffractive optical power region
US9812096B2 (en) * 2008-01-23 2017-11-07 Spy Eye, Llc Eye mounted displays and systems using eye mounted displays
US20090219606A1 (en) * 2008-03-03 2009-09-03 General Electric Company Device and method
US7931832B2 (en) * 2008-03-31 2011-04-26 Johnson & Johnson Vision Care, Inc. Ophthalmic lens media insert
US20100060991A1 (en) * 2008-09-11 2010-03-11 Omnivision Technologies, Inc. Electrically-Controlled, Variable Focal Length Liquid-Based Optical Imaging Apparatus and Method
WO2011067391A1 (en) * 2009-12-04 2011-06-09 Varioptic Electronically controlled focusing ophthalmic device
WO2013033337A1 (en) * 2011-08-31 2013-03-07 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with improved saline formulation
US9072465B2 (en) * 2012-04-03 2015-07-07 Johnson & Johnson Vision Care, Inc. Blink detection system for electronic ophthalmic lens
US20150124311A1 (en) * 2012-04-16 2015-05-07 Parrot Electrowetting optical device with low power consumption
CN103454705B (en) * 2012-06-04 2015-07-29 清华大学 Liquid lens
WO2014004836A1 (en) * 2012-06-29 2014-01-03 Johnson & Johnson Vision Care, Inc. Variable focus electroactive ophthalmic device
IL231344B (en) * 2013-03-13 2018-08-30 Johnson & Johnson Vision Care Methods of manufacture and use of energized ophthalmic devices having an electrical storage mode
US9389433B2 (en) * 2013-03-15 2016-07-12 Johnson Johnson Vision Care, Inc. Methods and apparatus to form ophthalmic devices incorporating photonic elements
US9841614B2 (en) 2014-06-13 2017-12-12 Verily Life Sciences Llc Flexible conductor for use within a contact lens
US9678361B2 (en) 2014-06-13 2017-06-13 Verily Life Sciences Llc Power delivery for accommodation by an eye-mountable device
US9933634B2 (en) 2014-06-13 2018-04-03 Verily Life Sciences Llc Apparatus, system and method for gaze tracking based on photodetection by an eye-mountable device
US9442311B2 (en) 2014-06-13 2016-09-13 Verily Life Sciences Llc Contact lens with capacitive gaze tracking
US9442310B2 (en) 2014-06-13 2016-09-13 Verily Life Sciences Llc Capacitive gaze tracking for auto-accommodation in a contact lens
US9854437B1 (en) 2014-06-13 2017-12-26 Verily Life Sciences Llc Apparatus, system and method for exchanging encrypted communications with an eye-mountable device
US10317702B2 (en) 2014-06-13 2019-06-11 Verily Life Sciences Llc Failsafe operation of eye-mountable device
US9880401B2 (en) 2014-06-13 2018-01-30 Verily Life Sciences Llc Method, device and system for accessing an eye-mountable device with a user interface
US9690118B2 (en) * 2014-06-13 2017-06-27 Verily Life Sciences Llc Eye-mountable device to provide automatic accommodation and method of making same
US9952358B2 (en) 2015-04-11 2018-04-24 Corning Incorporated Method to prevent emulsion in a liquid lens
US10139521B2 (en) * 2016-04-20 2018-11-27 Coopervision International Holding Company, Lp Silicone elastomer-hydrogel hybrid contact lenses
MY185355A (en) * 2016-04-20 2021-05-10 Coopervision Int Ltd Silicone elastomer-silicone hydrogel hybrid contact lenses
US10869753B1 (en) * 2017-05-05 2020-12-22 Verily Life Sciences Llc Electrowetting lens comprising phase change fluids
CN106950721B (en) * 2017-05-23 2019-03-01 京东方科技集团股份有限公司 A kind of glasses
US20190069989A1 (en) 2017-09-06 2019-03-07 Verily Life Sciences Llc Multipart electrowetting intraocular lens for in-situ assembly
US11394296B2 (en) * 2017-10-11 2022-07-19 Verily Life Sciences Llc Voltage driver for electrowetting lens
GB202319521D0 (en) * 2021-05-25 2024-01-31 Actuated Medical Inc Oscillation-aided implant insertion system and device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712721A (en) * 1993-04-07 1998-01-27 Technology Partnership, Plc Switchable lens
WO2000058763A1 (en) * 1999-03-26 2000-10-05 Universite Joseph Fourier Drop centering device
US6369954B1 (en) * 1997-10-08 2002-04-09 Universite Joseph Fourier Lens with variable focus
WO2004050334A1 (en) 2002-12-03 2004-06-17 Koninklijke Philips Electronics N.V. Manufacturing of lens elements

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6299720A (en) * 1985-10-25 1987-05-09 Toomee Sangyo Kk Contact lens material
JP2802287B2 (en) * 1988-05-31 1998-09-24 ピルキングトン ビジョンケア インコーポレイテッド Contact lens material and its manufacturing method
JPH0919494A (en) * 1995-07-04 1997-01-21 Mitsui Petrochem Ind Ltd Molded article for medical treatment and medicine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712721A (en) * 1993-04-07 1998-01-27 Technology Partnership, Plc Switchable lens
US6369954B1 (en) * 1997-10-08 2002-04-09 Universite Joseph Fourier Lens with variable focus
WO2000058763A1 (en) * 1999-03-26 2000-10-05 Universite Joseph Fourier Drop centering device
WO2004050334A1 (en) 2002-12-03 2004-06-17 Koninklijke Philips Electronics N.V. Manufacturing of lens elements

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BERGE B ET AL: "Variable focal lens controlled by an external voltage: an application of electrowetting", EUROPEAN PHYSICAL JOURNAL E. SOFT MATTER, EDP SCIENCES, IT, vol. 3, no. 2, October 2000 (2000-10-01), pages 159 - 163, XP002285977, ISSN: 1292-8941 *
GLEB VDOVIN: "On the possibility of intraocular adaptive optics", OPTICS EXPRESS, vol. 11, no. 7, 7 April 2003 (2003-04-07), pages 810 - 817, XP002323798 *

Cited By (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8460376B2 (en) * 2005-05-27 2013-06-11 Wavelight Laser Technologie Ag Intraocular lens
US20080306589A1 (en) * 2005-05-27 2008-12-11 Wavelight Laser Technologie Ag Intraocular Lens
EP1996968B1 (en) * 2006-03-21 2017-03-08 Parrot Drones Intraocular implant
WO2007107589A1 (en) * 2006-03-21 2007-09-27 Varioptic Intraocular implant
WO2008062067A1 (en) * 2006-11-24 2008-05-29 Varioptic Optical lens with variable focal length
US7864440B2 (en) 2006-11-24 2011-01-04 Varioptic, S.A. Optical lens with variable focal length
US9180636B2 (en) 2008-09-30 2015-11-10 Johnson & Johnson Vision Care, Inc. Variable focus ophthalmic device
US20100109175A1 (en) * 2008-10-31 2010-05-06 Pugh Randall B Processor controlled ophthalmic device
EP2349699B1 (en) * 2008-10-31 2016-08-03 Johnson & Johnson Vision Care Inc. Method and apparatus for forming an ophthalmic lens with embedded data processor
US9375886B2 (en) * 2008-10-31 2016-06-28 Johnson & Johnson Vision Care Inc. Ophthalmic device with embedded microcontroller
US9375885B2 (en) * 2008-10-31 2016-06-28 Johnson & Johnson Vision Care, Inc. Processor controlled ophthalmic device
US20100110372A1 (en) * 2008-10-31 2010-05-06 Pugh Randall B Ophthalmic device with embedded microcontroller
JP2017173853A (en) * 2008-10-31 2017-09-28 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッドJohnson & Johnson Vision Care, Inc. Method for forming ophthalmological lenses equipped with embedded microcontroller
US10251975B2 (en) 2009-02-19 2019-04-09 Neoss Limited Surface treatment process for implantable medical device
US9675443B2 (en) 2009-09-10 2017-06-13 Johnson & Johnson Vision Care, Inc. Energized ophthalmic lens including stacked integrated components
CN102884454A (en) * 2010-05-14 2013-01-16 庄臣及庄臣视力保护公司 Arcuate liquid meniscus lens
CN102884454B (en) * 2010-05-14 2015-07-15 庄臣及庄臣视力保护公司 Arcuate liquid meniscus lens
WO2011143554A1 (en) * 2010-05-14 2011-11-17 Johnson & Johnson Vision Care, Inc. Arcuate liquid meniscus lens
AU2011252875B2 (en) * 2010-05-14 2015-09-17 Johnson & Johnson Vision Care, Inc. Arcuate liquid meniscus lens
US9182521B2 (en) 2010-05-14 2015-11-10 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens including variable voltage zones
US8665526B2 (en) 2010-05-14 2014-03-04 Johnson & Johnson Vision Care, Inc. Arcuate liquid meniscus lens
US8743467B2 (en) 2010-06-29 2014-06-03 Johnson & Johnson Vision Care, Inc. Lens with conical frustum meniscus wall
RU2570335C2 (en) * 2010-07-27 2015-12-10 Джонсон Энд Джонсон Вижн Кэа, Инк. Liquid meniscus lens with meniscus convex wall shaped to torus segment
AU2011282930B2 (en) * 2010-07-27 2015-09-03 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with convex torus-segment meniscus wall
US8638501B2 (en) 2010-07-27 2014-01-28 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with convex torus-segment meniscus wall
WO2012015719A1 (en) * 2010-07-27 2012-02-02 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with convex torussegment meniscus wall
AU2015224524B2 (en) * 2010-07-29 2016-10-20 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with concave torus-segment meniscus wall
WO2012015725A1 (en) * 2010-07-29 2012-02-02 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with concave torus-segment meniscus wall
US8634145B2 (en) 2010-07-29 2014-01-21 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with concave torus-segment meniscus wall
TWI494610B (en) * 2010-07-29 2015-08-01 Johnson & Johnson Vision Care Liquid meniscus lens with concave torus-segment meniscus wall
WO2012027155A1 (en) * 2010-08-23 2012-03-01 Johnson & Johnson Vision Care, Inc. Negative add liquid meniscus lens
US8767308B2 (en) 2010-08-23 2014-07-01 Johnson & Johnson Vision Care, Inc Negative add liquid meniscus lens
CN103069313A (en) * 2010-08-23 2013-04-24 庄臣及庄臣视力保护公司 Negative add liquid meniscus lens
CN103069312A (en) * 2010-08-24 2013-04-24 庄臣及庄臣视力保护公司 Lens with compound linear-convex meniscus wall
WO2012027156A1 (en) * 2010-08-24 2012-03-01 Johnson & Johnson Vision Care, Inc. Lens with compound linear-convex meniscus wall
US8693104B2 (en) 2010-08-24 2014-04-08 Johnson & Johnson Vision Care, Inc. Lens with compound linear-convex meniscus wall
WO2012033795A1 (en) * 2010-09-08 2012-03-15 Johnson & Johnson Vision Care, Inc. Lens with multi-convex meniscus wall
US8767309B2 (en) 2010-09-08 2014-07-01 Johnson & Johnson Vision Care, Inc. Lens with multi-convex meniscus wall
CN103080781A (en) * 2010-09-08 2013-05-01 庄臣及庄臣视力保护公司 Lens with multi-convex meniscus wall
CN103080781B (en) * 2010-09-08 2015-05-20 庄臣及庄臣视力保护公司 Lens with multi-convex meniscus wall
US8526113B2 (en) 2010-09-27 2013-09-03 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens including gradient thickness dielectric coating
CN103124920A (en) * 2010-09-27 2013-05-29 庄臣及庄臣视力保护公司 Liquid meniscus lens including gradient thickness dielectric coating
WO2012044589A1 (en) * 2010-09-27 2012-04-05 Johnson & Johnson Vision Care, Inc. Lens with multi-segmented linear meniscus wall
WO2012044598A1 (en) * 2010-09-27 2012-04-05 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens including gradient thickness dielectric coating
US10520753B2 (en) 2010-09-27 2019-12-31 Johnson & Johnson Vision Care, Inc. Lens with multi-segmented linear meniscus wall
AU2011307321B2 (en) * 2010-09-27 2015-04-23 Johnson & Johnson Vision Care, Inc. Lens with multi-segmented linear meniscus wall
CN103140780A (en) * 2010-09-29 2013-06-05 庄臣及庄臣视力保护公司 Liquid meniscus lens with non-spherical meniscus wall
US8687280B2 (en) 2010-09-29 2014-04-01 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens including meniscus wall with microchannels
WO2012044607A1 (en) * 2010-09-29 2012-04-05 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with non-spherical meniscus wall
CN103140779A (en) * 2010-09-29 2013-06-05 庄臣及庄臣视力保护公司 Liquid meniscus lens including variable voltage zones
US8638502B2 (en) 2010-09-29 2014-01-28 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with non-spherical meniscus wall
US9500884B2 (en) 2010-10-11 2016-11-22 Adiens Beacon Inc. Fluid filled adjustable contact lenses
EP2628044A1 (en) * 2010-10-11 2013-08-21 Adlens Beacon, Inc. Fluid filled adjustable contact lenses
EP2628044A4 (en) * 2010-10-11 2014-06-04 Adlens Beacon Inc Fluid filled adjustable contact lenses
US9703120B2 (en) 2011-02-28 2017-07-11 Johnson & Johnson Vision Care, Inc. Methods and apparatus for an ophthalmic lens with functional insert layers
US9914273B2 (en) 2011-03-18 2018-03-13 Johnson & Johnson Vision Care, Inc. Method for using a stacked integrated component media insert in an ophthalmic device
US8867141B2 (en) 2011-03-18 2014-10-21 Johnson & Johnson Vision Care, Inc. Lens with multi-concave meniscus wall
CN103443665B (en) * 2011-03-18 2016-04-27 庄臣及庄臣视力保护公司 There are the lens of multi-concave bent moon wall
US9889615B2 (en) 2011-03-18 2018-02-13 Johnson & Johnson Vision Care, Inc. Stacked integrated component media insert for an ophthalmic device
CN103443665A (en) * 2011-03-18 2013-12-11 庄臣及庄臣视力保护公司 Lens with multi-oncave meniscus wall
WO2012129050A1 (en) * 2011-03-18 2012-09-27 Johnson & Johnson Vision Care, Inc. Lens with multi-concave meniscus wall
AU2012231241B2 (en) * 2011-03-18 2015-09-03 Johnson & Johnson Vision Care, Inc. Lens with multi-concave meniscus wall
US9535268B2 (en) 2011-03-18 2017-01-03 Johnson & Johnson Vision Care, Inc. Multiple energization elements in stacked integrated component devices
US10451897B2 (en) 2011-03-18 2019-10-22 Johnson & Johnson Vision Care, Inc. Components with multiple energization elements for biomedical devices
US9110310B2 (en) 2011-03-18 2015-08-18 Johnson & Johnson Vision Care, Inc. Multiple energization elements in stacked integrated component devices
US9698129B2 (en) 2011-03-18 2017-07-04 Johnson & Johnson Vision Care, Inc. Stacked integrated component devices with energization
US9804418B2 (en) 2011-03-21 2017-10-31 Johnson & Johnson Vision Care, Inc. Methods and apparatus for functional insert with power layer
CN102415935A (en) * 2011-07-22 2012-04-18 季鹏飞 Electric zoom myopia physiotherapeutic spectacles
RU2594435C2 (en) * 2011-08-31 2016-08-20 Джонсон Энд Джонсон Вижн Кэа, Инк. Intraocular lens system with processor control
EP3213713A1 (en) * 2011-08-31 2017-09-06 Johnson & Johnson Vision Care, Inc. Processor controlled intraocular lens system
WO2013033349A1 (en) * 2011-08-31 2013-03-07 Johnson & Johnson Vision Care, Inc. Processor controlled intraocular lens system
CN103764070B (en) * 2011-08-31 2016-03-09 庄臣及庄臣视力保护公司 The intraocular lens system that processor controls
US10052196B2 (en) 2011-08-31 2018-08-21 Johnson & Johnson Vision Care, Inc. Processor controlled intraocular lens system
CN103764070A (en) * 2011-08-31 2014-04-30 庄臣及庄臣视力保护公司 Processor controlled intraocular lens system
US10775644B2 (en) 2012-01-26 2020-09-15 Johnson & Johnson Vision Care, Inc. Ophthalmic lens assembly having an integrated antenna structure
US9958703B2 (en) 2012-03-30 2018-05-01 Johnson & Johnson Vision Care, Inc. Method and apparatus for a variable power opthalmic lens
US9158127B2 (en) 2012-03-30 2015-10-13 Johnson & Johnson Vision Care, Inc. Method and apparatus for a variable power ophthalmic lens
US10409089B2 (en) 2012-06-29 2019-09-10 Johnson & Johnson Vision Care, Inc. Multiple state electroactive ophthalmic device
CN102768416A (en) * 2012-07-31 2012-11-07 苏州苏鼎产品设计有限公司 Layered liquid sunglasses
US9757911B2 (en) 2013-01-09 2017-09-12 Johnson & Johson Vision Care, Inc. Method of forming a multi-piece insert device with seal for ophthalmic devices
US9810924B2 (en) 2013-01-09 2017-11-07 Johnson & Johnson Vision Care, Inc. Multi-piece insert device with locking seal for ophthalmic devices
EP2778747A3 (en) * 2013-03-15 2014-11-26 Johnson & Johnson Vision Care, Inc. Ophthalmic lens viewing sets for three-dimensional perception of stereoscopic media
US9873233B2 (en) 2013-03-15 2018-01-23 Johnson & Johnson Vision Care, Inc. Ophthalmic lens viewing sets for three-dimensional perception of stereoscopic media
CN104076526A (en) * 2013-03-15 2014-10-01 庄臣及庄臣视力保护公司 Ophthalmic lens viewing sets for three-dimensional perception of stereoscopic media
CN104076526B (en) * 2013-03-15 2018-12-04 庄臣及庄臣视力保护公司 The ophthalmic lens of three-dimensional perception for three-dimensional medium watch suit
US10361405B2 (en) 2014-08-21 2019-07-23 Johnson & Johnson Vision Care, Inc. Biomedical energization elements with polymer electrolytes
US10598958B2 (en) 2014-08-21 2020-03-24 Johnson & Johnson Vision Care, Inc. Device and methods for sealing and encapsulation for biocompatible energization elements
US10361404B2 (en) 2014-08-21 2019-07-23 Johnson & Johnson Vision Care, Inc. Anodes for use in biocompatible energization elements
US10367233B2 (en) 2014-08-21 2019-07-30 Johnson & Johnson Vision Care, Inc. Biomedical energization elements with polymer electrolytes and cavity structures
US10374216B2 (en) 2014-08-21 2019-08-06 Johnson & Johnson Vision Care, Inc. Pellet form cathode for use in a biocompatible battery
US10381687B2 (en) 2014-08-21 2019-08-13 Johnson & Johnson Vision Care, Inc. Methods of forming biocompatible rechargable energization elements for biomedical devices
US10386656B2 (en) 2014-08-21 2019-08-20 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form separators for biocompatible energization elements for biomedical devices
US10558062B2 (en) 2014-08-21 2020-02-11 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form biocompatible energization primary elements for biomedical device
US10627651B2 (en) 2014-08-21 2020-04-21 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form biocompatible energization primary elements for biomedical devices with electroless sealing layers
US10345620B2 (en) 2016-02-18 2019-07-09 Johnson & Johnson Vision Care, Inc. Methods and apparatus to form biocompatible energization elements incorporating fuel cells for biomedical devices
US10509238B2 (en) 2017-04-14 2019-12-17 Verily Life Sciences Llc Electrowetting opthalmic optics including gas-permeable components
CN110537137A (en) * 2017-04-14 2019-12-03 威里利生命科学有限责任公司 Electrowetting opticianry device including breathability feature
WO2018190998A1 (en) * 2017-04-14 2018-10-18 Verily Life Sciences Llc Electrowetting ophthalmic optics including gas-permeable components
CN110537137B (en) * 2017-04-14 2021-12-14 威里利生命科学有限责任公司 Electrowetting contact lens and eye-mountable accommodation device
CN110545755A (en) * 2017-05-05 2019-12-06 威里利生命科学有限责任公司 In situ filling and sealing of electrowetting intraocular lenses
WO2018204027A1 (en) * 2017-05-05 2018-11-08 Verily Life Sciences Llc In situ filling and sealing of electrowetting intraocular lenses
US11197752B2 (en) 2017-05-05 2021-12-14 Verily Life Sciences Llc Situ filling and sealing of electrowetting intraocular lenses
CN107179611A (en) * 2017-07-06 2017-09-19 惠科股份有限公司 A kind of wearable device, stereoscopic picture plane play system and method
WO2019006843A1 (en) * 2017-07-06 2019-01-10 惠科股份有限公司 Wearable device, stereoscopic picture playing system and method
US11366335B2 (en) 2017-07-06 2022-06-21 HKC Corporation Limited Wearable device and 3D display system and method
WO2020132443A3 (en) * 2018-12-21 2020-08-13 Verily Life Sciences Llc Fluid-containing contact lens with soft posterior element
US11703697B2 (en) 2018-12-21 2023-07-18 Verily Life Sciences Llc Fluid-containing contact lens with soft posterior element

Also Published As

Publication number Publication date
EP1728117A1 (en) 2006-12-06
JP2007526517A (en) 2007-09-13
US20070153405A1 (en) 2007-07-05
US7311398B2 (en) 2007-12-25

Similar Documents

Publication Publication Date Title
US7311398B2 (en) Variable focus lens
US9927634B2 (en) Switchable spectacles
KR102080980B1 (en) Ophthalmic implants with extended depth of field and enhanced distance visual acuity
CA2455076C (en) Intraocular lens implant
US10918476B2 (en) Electrowetting intraocular lens with isotonic aqueous phase
US8603164B2 (en) Adjustable fluidic telescope
US20130261744A1 (en) Implantable ophthalmic device with an aspheric lens
US20120290084A1 (en) Ocular auto-focusing lenses
US8409278B2 (en) External lens with flexible membranes for automatic correction of the refractive errors of a person
JP2007513709A (en) Multifocal intraocular lens and method of making and using the same
US10932902B2 (en) Dynamically tunable apodized multiple-focus opthalmic devices and methods
KR20070065899A (en) Electro-active intraocular lenses
US20150219925A1 (en) Movable ophthalmic lens assembly
RU2665203C2 (en) Comfort-optimised contact lens system for non-rotationally symmetric eye aberration
US20210181531A1 (en) Dynamically tunable apodized multiple-focus opthalmic devices and methods
EP0578739B1 (en) Bifocal intraocular lens with spherical aberration correction
EP1954213A2 (en) Multi-focal prosthesis, and methods for making and using same
AU2006200142B2 (en) Ocular auto-focusing lenses
EP2820465B1 (en) Refractive-difractive switchable optical element

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005708847

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10598258

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2007501415

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 2005708847

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10598258

Country of ref document: US